Cegedim SA (0DYQ.L)
EUR 13.5
(0.0%)
EUR 13.5
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 629.51 Million EUR | 7.47% |
| 2022 | 585.78 Million EUR | 3.64% |
| 2021 | 565.19 Million EUR | -18.96% |
| 2020 | 697.45 Million EUR | 14.83% |
| 2019 | 607.36 Million EUR | 35.23% |
| 2018 | 449.15 Million EUR | -18.17% |
| 2017 | 548.87 Million EUR | 5.53% |
| 2016 | 520.13 Million EUR | -18.24% |
| 2015 | 636.15 Million EUR | -31.68% |
| 2014 | 931.16 Million EUR | 6.38% |
| 2013 | 875.35 Million EUR | 1.43% |
| 2012 | 863.03 Million EUR | -1.6% |
| 2011 | 877.08 Million EUR | -2.19% |
| 2010 | 896.71 Million EUR | 3.99% |
| 2009 | 862.35 Million EUR | -18.23% |
| 2008 | 1.05 Billion EUR | 1.23% |
| 2007 | 1.04 Billion EUR | 161.15% |
| 2006 | 398.92 Million EUR | 95.52% |
| 2005 | 204.03 Million EUR | -30.58% |
| 2004 | 293.92 Million EUR | 32.32% |
| 2003 | 222.13 Million EUR | 18.84% |
| 2002 | 186.91 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 687.43 Million EUR | 0.0% |
| 2024 Q1 | 687.43 Million EUR | 9.2% |
| 2023 FY | 629.51 Million EUR | 7.47% |
| 2023 Q2 | 603.33 Million EUR | 0.0% |
| 2023 Q3 | 629.51 Million EUR | 4.34% |
| 2023 Q1 | 603.33 Million EUR | 3.0% |
| 2023 Q4 | 629.51 Million EUR | 0.0% |
| 2022 Q4 | 585.78 Million EUR | 0.0% |
| 2022 FY | 585.78 Million EUR | 3.64% |
| 2022 Q1 | 571.42 Million EUR | 1.1% |
| 2022 Q2 | 571.42 Million EUR | -0.0% |
| 2022 Q3 | 585.78 Million EUR | 2.51% |
| 2021 Q1 | 580.53 Million EUR | -16.76% |
| 2021 Q2 | 580.53 Million EUR | -0.0% |
| 2021 FY | 565.19 Million EUR | -18.96% |
| 2021 Q4 | 565.19 Million EUR | 0.0% |
| 2021 Q3 | 565.19 Million EUR | -2.64% |
| 2020 Q4 | 697.45 Million EUR | 0.0% |
| 2020 Q1 | 679.03 Million EUR | 11.8% |
| 2020 Q2 | 679.03 Million EUR | 0.0% |
| 2020 Q3 | 697.45 Million EUR | 2.71% |
| 2020 FY | 697.45 Million EUR | 14.83% |
| 2019 Q2 | 556.44 Million EUR | 0.0% |
| 2019 FY | 607.36 Million EUR | 35.23% |
| 2019 Q4 | 607.36 Million EUR | 0.0% |
| 2019 Q3 | 607.36 Million EUR | 9.15% |
| 2019 Q1 | 556.44 Million EUR | 23.89% |
| 2018 FY | 449.15 Million EUR | -18.17% |
| 2018 Q4 | 449.15 Million EUR | 0.0% |
| 2018 Q3 | 449.15 Million EUR | 12.72% |
| 2018 Q2 | 398.46 Million EUR | 0.0% |
| 2018 Q1 | 398.46 Million EUR | -27.4% |
| 2017 FY | 548.87 Million EUR | 5.53% |
| 2017 Q4 | 548.87 Million EUR | 0.0% |
| 2017 Q3 | 548.87 Million EUR | 5.84% |
| 2017 Q2 | 518.58 Million EUR | 0.0% |
| 2017 Q1 | 518.58 Million EUR | -0.3% |
| 2016 Q2 | 467.85 Million EUR | 0.25% |
| 2016 FY | 520.13 Million EUR | -18.24% |
| 2016 Q3 | 464.52 Million EUR | -0.71% |
| 2016 Q4 | 520.13 Million EUR | 11.97% |
| 2016 Q1 | 466.7 Million EUR | -26.64% |
| 2015 Q3 | 600.19 Million EUR | -12.58% |
| 2015 FY | 636.15 Million EUR | -31.68% |
| 2015 Q4 | 636.15 Million EUR | 5.99% |
| 2015 Q2 | 686.55 Million EUR | -27.19% |
| 2015 Q1 | 942.97 Million EUR | 1.27% |
| 2014 Q3 | 880.83 Million EUR | -2.37% |
| 2014 FY | 931.16 Million EUR | 6.38% |
| 2014 Q1 | 854.99 Million EUR | -2.33% |
| 2014 Q2 | 902.19 Million EUR | 5.52% |
| 2014 Q4 | 931.16 Million EUR | 5.71% |
| 2013 Q4 | 875.35 Million EUR | -1.21% |
| 2013 FY | 875.35 Million EUR | 1.43% |
| 2013 Q2 | 897.75 Million EUR | 2.43% |
| 2013 Q1 | 876.42 Million EUR | 1.55% |
| 2013 Q3 | 886.1 Million EUR | -1.3% |
| 2012 FY | 863.03 Million EUR | -1.6% |
| 2012 Q2 | 847.72 Million EUR | 0.0% |
| 2012 Q4 | 863.03 Million EUR | 0.0% |
| 2011 Q2 | 887.47 Million EUR | 0.0% |
| 2011 Q4 | 877.08 Million EUR | 0.0% |
| 2011 FY | 877.08 Million EUR | -2.19% |
| 2010 Q4 | 896.71 Million EUR | 0.0% |
| 2010 Q2 | 974.82 Million EUR | 0.0% |
| 2010 FY | 896.71 Million EUR | 3.99% |
| 2009 FY | 862.35 Million EUR | -18.23% |
| 2009 Q4 | 862.35 Million EUR | 0.0% |
| 2008 FY | 1.05 Billion EUR | 1.23% |
| 2007 FY | 1.04 Billion EUR | 161.15% |
| 2006 FY | 398.92 Million EUR | 95.52% |
| 2005 FY | 204.03 Million EUR | -30.58% |
| 2004 FY | 293.92 Million EUR | 32.32% |
| 2003 FY | 222.13 Million EUR | 18.84% |
| 2002 FY | 186.91 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Guerbet SA | 646.97 Million EUR | 2.698% |
| Nexus AG | 153.13 Million EUR | -311.086% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | -11.154% |
| Revenio Group Oyj | 37.6 Million EUR | -1574.234% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 65.919% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 91.004% |
| LNA Santé SA | 1.19 Billion EUR | 47.48% |
| Siemens Healthineers AG | 28.55 Billion EUR | 97.795% |
| Medios AG | 125.94 Million EUR | -399.827% |
| Equasens Société anonyme | 166.41 Million EUR | -278.269% |
| Stratec SE | 246.2 Million EUR | -155.686% |